Peptides and Metabolic Health: A Synergistic Approach Peptides are not standalone solutions
Subcutaneous is the standard for self-administered BPC-157 knee protocols
In this game, contamination is the fastest way to ruin your research, so taking a few minutes to prep properly is non-negotiable
Long-Term Protocols: The most clinically relevant studies evaluated subcutaneous doses of 0.25 mg (250 mcg), 0.5 mg (500 mcg), and 1 mg (1,000 mcg) administered daily for 24 weeks
TB-500 is usually injected under the skin
Investigators have assessed multiple administration routes, including subcutaneous, intramuscular, intravenous, oral, and topical delivery in experimental models